What does CUSIP 014339AA3 represent in this 13F holders report?

CUSIP 014339AA3 is the security identifier for 014339AA3 - ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 used to aggregate holder disclosures.

How many institutions held 014339AA3 - ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 in Q2 2018?

31 institutional investors reported 014339AA3 - ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 for Q2 2018. Use the holders table for investor-level position and value details.

ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0

CUSIP: 014339AA3

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Debt / NOTE 2.500% 2/0
Market price (% of par): 104.0%
Total 13F principal: $277,873,000
Principal change: +$9,021,000
Total reported market value: $289,388,277
Number of holders: 31
Value change: +$19,754,777
Number of buys: 15
Number of sells: 26

Quarterly Holders Quick Answers

What is CUSIP 014339AA3?
CUSIP 014339AA3 identifies 014339AA3 - ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 014339AA3:

Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018

Institutional Holders of ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 as of Q2 2018

As of 30 Jun 2018, ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 was held by 31 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $277,873,000 in principal (par value) of the bond. The largest 10 bondholders included Partner Fund Management, L.P., WOLVERINE ASSET MANAGEMENT LLC, Linden Advisors LP, CITADEL ADVISORS LLC, Redmile Group, LLC, AMUNDI PIONEER ASSET MANAGEMENT INC, Lion Point Capital, LP, AMERIPRISE FINANCIAL INC, BANK OF AMERICA CORP /DE/, and CREDIT SUISSE AG/. This page lists 31 institutional bondholders reporting positions for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price (% of par)	Principal	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.